REG - Seed Innovations Ltd - Transaction in Own Shares & TVR

Seed InnovationsAnnouncement

19/12/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231219:nRSS2098Xa&default-theme=true

RNS Number : 2098X  Seed Innovations Limited  19 December 2023

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic
Law by virtue of the European Union (Withdrawal) Act 2018. Upon the
publication of this announcement, this inside information is now considered to
be in the public domain.

 

19 December 2023

SEED Innovations Limited

("SEED" or the "Company")

Transaction in Own Shares & TVR

SEED Innovations Ltd, the AIM-quoted company investment company providing
shareholders with exposure to early-stage health, wellness and medical
cannabis companies to which, in normal circumstances, they have limited access
to, announces that it has purchased the following number of its shares of 1p
each on the London Stock Exchange to be held in treasury (through Shard
Capital Stockbrokers Limited ("Shard") acting as the Company's broker).

 Date of Purchase                                       18 December 2023
 Number of shares purchased (aggregated volume):        150,000
 Highest price paid per share (pence):                  2.05 pence
 Lowest price paid per share (pence):                   2.05 pence
 Volume weighted average price paid per share (pence):  2.05 pence

 

Following the purchase of these shares, the Company's issued ordinary share
capital consists of 215,219,841 ordinary shares of which a total of 11,281,446
shares are held in treasury. The remaining 203,938,395 shares represent the
total voting rights in the Company and may be used by shareholders as the
denominator for the calculations by which they can determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the Financial Conduct Authority's Disclosure and Transparency
Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No.
596/2014 which is part of UK law by virtue of the European Union (Withdrawal)
Act 2018, the table below contains detailed information of the individual
trades made by Shard on 18 December 2023 as part of the Programme as defined
by the Company in the announcement on 29 September 2023.

Aggregate information:

 Venue  Volume-weighted average price (pence per share)  Aggregated volume
 AIMX   2.05                                             150,000

 

 

 

 

 

 

 

Individual transactions:

 Number of shares purchased  Transaction price   Time of transaction  Venue

(pence per share)
 150,000                     2.05                14.10.40             AIMX

 

-Ends-

For further information on the Company please visit:  www.seedinnovations.co
(http://www.seedinnovations.com/) or contact:

 Ed McDermott       SEED Innovations Ltd         E: info@seedinnovations.co

 Lance de Jersey
 James Biddle       Beaumont Cornish Limited,    T: (0)20 7628 3396

 Roland Cornish     Nomad
 Isabella Pierre    Shard Capital Partners LLP   T: (0)20 7186 9927

 Damon Heath        Broker
 Catherine Leftley  St Brides Partners Ltd,      E: seed@stbridespartners.co.uk

 Ana Ribeiro        Financial PR

 Isabelle Morris

Notes

Seed Innovations Ltd

SEED Innovations is an AIM quoted investment company focused primarily on
disruptive high growth life sciences and technology businesses particularly
within the medical cannabis arena. The Company's strategy is to identify
early-stage opportunities that have an upcoming investment catalyst and grow
its portfolio in terms of value whilst limiting the number of investee
companies to a level where relevant time can be devoted to each.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSNKFBBOBDDFBD